tm logo

Monitor this mark

View On USPTO

OMRITURA
Dead/Cancelled
IR CANCELLED; US REGISTRATION CANCELLED

on 25 Nov 2023

Last Applicant/ Owned by

Novartis AG

CH-4002 Basel

CH

Serial Number

79141049 filed on 25th Nov 2013

Registration Number

4554021 registered on 24th Jun 2014

in the Principal Register

Correspondent Address

Maury M. Tepper, III

Maury M. Tepper, III Tepper & Eyster, PLLC

Raleigh, NC 27609

UNITED STATES

Filing Basis

1. filing basis filed as 66 a

Disclaimer

NO DATA

OMRITURA

Pharmaceutical preparations for human use for the prevention and treatment of immune system disorders, for use in oncology, and for use in tissue and organ transplantation

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceutical preparations for human use for the prevention and treatment of immune system disorders, for use in oncology, and for use in tissue and organ transplantation

First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details

Serial Number

No 79141049

Mark Type

No Service/Collective Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

Yes

66A Current

Yes

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
17th Jun 2024DEATH OF INTERNATIONAL REGISTRATION
17th Jun 2024NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
17th Apr 2022TOTAL INVALIDATION PROCESSED BY THE IB
07th Mar 2022INVALIDATION PROCESSED
07th Mar 2022TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
26th Oct 2021TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
26th Feb 2021CANCELLED SECTION 71
24th Jun 2019COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
03rd Jan 2015FINAL DECISION TRANSACTION PROCESSED BY IB
09th Dec 2014FINAL DISPOSITION NOTICE SENT TO IB